Osteoarthritis (OA)

CHF 61.80
Auf Lager
SKU
PCS4VB53RPN
Stock 1 Verfügbar
Geliefert zwischen Fr., 26.09.2025 und Mo., 29.09.2025

Details

Osteoarthritis (OA) is defined as a focal lesion of the articular cartilage, combined with a hypertrophic reaction (sclerosis) in the subchondral bone and new bone formation (osteophytes) at the joint margins (Van den Berg, 2000). OA is associated with a loss of balance between synthesis and degradation of macromolecules needed to provide articular cartilage with its biomechanical and functional properties. At the same time, changes occur in the structure and metabolism of synovium, subchondral bone and other tissues of joint. Conventional therapeutic options employed in the management of osteoarthritis are simple analgesics & NSAIDs, but these options produce sub-optimal benefits and are associated with adverse-safety profile (Walker- Bone, 2003). NSAIDs, in particular can cause serious side effects including peptic ulcer and hepatic or renal failure (Sanghi et al., 2009). Other available therapies like nutraceuticals (e.g. glucosamine, chondriotin sulfate etc.) and various anti-oxidants (e.g. Vitamin E, selenium, niacinamide, etc.) are also not so effective in delay of progression of OA (Reichenbach et al., 2007; Brand et al., 2001; Hill et al., 1990; Jonas et al., 1996).

Autorentext

Author of 17 books in various fields. M.Litt.(Education) and Ph.D. (Education Psychology), served as Vocational Guidance Officer with Employment Department, Government of Punjab, India.Sandeep Kaur, co-author, an Educationist and working as Teacher.Bhupinder Singh Bhalla, co-author, Graduate in Electronic Engineering.

Cart 30 Tage Rückgaberecht
Cart Garantie

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Titel Osteoarthritis (OA)
    • ISBN 978-3-659-25687-5
    • Format Kartonierter Einband (Kt)
    • EAN 9783659256875
    • Jahr 2012
    • Größe H6mm x B220mm x T150mm
    • Autor Ripudaman Singh , Kanchan Vohra , Harpreet Singh Kalra
    • Untertitel Role of Advanced Glycation End Products (AGEs)inhibitor
    • Gewicht 180g
    • Genre Medizin
    • Anzahl Seiten 108
    • Herausgeber LAP Lambert Academic Publishing
    • GTIN 09783659256875

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.